GILEAD SCIENCES, INC.
CIK
882095
Location
FOSTER CITY, CA
Portfolio Value
Mid
$1,649,480,361
Diversification
Highly concentrated
Reports for
Gilead Therapeutics A1 Unlimited Co
Filing Date
Global Rank
#1,826
/ 8,795
▼ 66
· as of Jun 2026
Top Industry
Biotechnology
100.0%
Period ended 3 months ago
Filed Aug 3, 2026 · 2mo
7 quarters · since Dec 2024
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
5 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
58.7%
+8.3 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
4,446
Highly concentrated+423
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,649,480,361 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ASMB | Assembly Biosciences, Inc. | +471,698 | 4,977,089 | $136,770,405 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 6,720,803 | $0 | ||
| No positions match the current search. | ||||
5 tracked positions ·
$1,649,480,361 total
· filing declares
5 positions · $1,648,747,919
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 31,424,760 | $968,825,350 | 58.74% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
Held | 16,707,477 | $500,890,160 | 30.37% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 4,977,089 | $136,770,405 | 8.29% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
Held | 4,126,119 | $36,763,720 | 2.23% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Held | 650,389 | $6,230,726 | 0.38% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.